NCT05243329 Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder Status UNKNOWN Phase PHASE2
NCT05242029 Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use Status WITHDRAWN Phase PHASE2
NCT05220410 The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation Status COMPLETED Phase PHASE2
NCT05220046 Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers Status COMPLETED Phase PHASE1
NCT05128162 Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia Status COMPLETED Phase PHASE2
NCT04982796 Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04950608 Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care Status COMPLETED Phase PHASE2
NCT04905121 Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA) Status TERMINATED Phase PHASE1
NCT04754061 PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04739865 The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression Status COMPLETED Phase PHASE2
NCT04718792 Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04670081 Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression Status COMPLETED Phase PHASE2
NCT04661514 Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy Status COMPLETED Phase PHASE2
NCT04656301 Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder Status COMPLETED Phase PHASE2